Companies: 10,795·Total market cap: $144.5T
Oragenics, Inc.

Oragenics, Inc.

OGENAMEXHealthcare● Active
$0.61
+$0.02(+2.61%)
Market Cap$2750038
P/E Ratio
52W High$5.24
52W Low$0.5
Overview

Oragenics, Inc.(OGEN)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · OGEN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-6.11ogen eps ttm · ogen earnings per shareEarnings history
PE Ratio (TTM)ogen pe ratio ttm · ogen price to earningsPE Ratio deep dive
Revenue (TTM)0.00ogen revenue ttm · ogen annual revenueFull revenue history
Dividend Yield不分红does ogen pay dividends · ogen dividend yieldDividend history
Shares Outstanding2.2Mogen shares outstanding · ogen floatShares outstanding history
Next EarningsAug 11, 2026Est.ogen earnings date · ogen next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
oragenics, inc. revenue · ogen revenue 2025
FY 2025Net Income-$9.8M▲ +6.86% YoY
202320242025
oragenics, inc. net income · ogen profit 2025
FY 2025EPS$-4.56▼ 185.00% YoY
202320242025
ogen eps · oragenics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$9.8MEPS: $-6.11View income statement →

分析师评级与目标价

完整预测
SellBuy
Hold3 位分析师is ogen a buy · ogen analyst rating
Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.61Current
$Avg Target
$High
ogen price target · ogen 12 month forecast

合计: 3 · 买入占比: 0.0%

股票表现

完整历史
1D+2.61%
1W+2.06%
1M+2.09%
3M-32.27%
YTD-22.18%
1Y-85.92%
5Y-99.96%

关于 Oragenics, Inc.

CEOJanet Huffman
IPO DateFeb 25, 2004
Employees3
CountryUS

Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the …

what is oragenics, inc. · ogen stock overview · oragenics, inc. company profile · who is oragenics, inc. ceo · ogen AMEX · oragenics, inc. headquarters · oragenics, inc. business segments

关于股票概览与关键数据

Oragenics, Inc.(OGEN)是 Biotechnology 行业的 Healthcare 类公司,于 Feb 25, 2004 在 AMEX 上市。截至最近交易日,OGEN 股价为 $0.61,市值约为 $2.8M。过去12个月累计回报 -85.92%,年初至今回报 -22.18%。

根据 3 位华尔街分析师,Oragenics, Inc. 股票共识评级为Hold,12个月平均目标价为 $—。2025 财年 Oragenics, Inc. 营收 —,净利润 -$9.8M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Oragenics, Inc.(OGEN)股价为 $0.61,在 AMEX 上市,52周区间为 $0.50 – $5.24。

OGEN 最新股价OGEN quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议